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Abstract 
Background and purpose:  To evaluate non-coplanar volumetric modulated arc radiotherapy 
(VMAT) trajectories for organ at risk (OAR) sparing in primary brain tumour radiotherapy.   
Materials and methods:  Fifteen patients were planned using coplanar VMAT and compared 
against non-coplanar VMAT plans for three trajectory optimization techniques.  A geometric 
heuristic technique (GH) combined beam scoring and Dijkstra's algorithm to minimize the 
importance-weighted sum of OAR volumes irradiated.  Fluence optimization was used to 
perform a local search around coplanar and GH trajectories, producing fluence-based local 
search (FBLS) and FBLS+GH trajectories respectively.  
Results: GH, FBLS, and FBLS+GH trajectories reduced doses to the contralateral globe, 
optic nerve, hippocampus, temporal lobe, and cochlea.  However, FBLS increased dose to the 
ipsilateral lens, optic nerve and globe.  Compared to GH, FBLS+GH increased dose to the 
ipsilateral temporal lobe and hippocampus, contralateral optics, and the brainstem and body.  
GH and FBLS+GH trajectories reduced bilateral hippocampi normal tissue complication 
probability (p = 0.028 and p = 0.043, respectively).  All techniques reduced PTV conformity; 
GH and FBLS+GH trajectories reduced homogeneity but less so for FBLS+GH.   
Conclusions:  The geometric heuristic technique best spared OARs and reduced normal tissue 
complication probability, however incorporating fluence information into non-coplanar 
trajectory optimization maintained PTV homogeneity.     
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Introduction 
Sparing organs at risk (OAR) in intracranial radiotherapy reduces the risk of side effects that 
affect quality of life, such as cranial and optic neuropathy, hearing loss, and neurocognitive 
impairment [1-6].  Using non-coplanar beam orientations has been shown to improve OAR 
dosimetry in conformal [7], intensity modulated (IMRT) [8], and volumetric modulated arc 
(VMAT) [9] radiation therapy.  However, non-coplanar geometries are fixed during delivery 
for a given beam, limiting their application to VMAT.  New linear accelerators can perform 
dynamic couch rotation during beam delivery, making possible non-coplanar VMAT 
trajectories that use more of the 4π space around the patient [10-12] and enabling potential 
additional reductions in normal tissue complication probability (NTCP). 
 
Early research into the clinical benefit of non-coplanar VMAT mainly focused on planner-
defined trajectories [13-15], while recent work has investigated trajectory optimization 
techniques [10, 16-19].  Published optimization techniques have used one of two approaches: 
geometric heuristics or fluence optimization.  Geometric heuristics score individual beam 
orientations and determine trajectories that minimize the overall score [10, 16, 17].  Fluence-
based techniques identify a smaller group of optimal candidate beam orientations, which are 
then connected via intermediate paths [18, 19].  Geometric heuristics are appealing due to the 
computational complexity of a full fluence search for a VMAT arc but lack the dosimetric 
information that can be utilized in fluence optimization. 
 
Smyth et al.         Non-coplanar trajectories for brain VMAT 4 
This paper proposes and evaluates three different trajectory optimization techniques - a 
geometric heuristic technique and two incorporating fluence optimization - for primary brain 
tumour radiotherapy using non-coplanar VMAT.  We aim to answer three questions: 
1. Does a geometric heuristic technique improve OAR sparing over coplanar VMAT?   
2. Does a fluence-based local search technique improve OAR sparing over coplanar VMAT?   
3. Is there a synergistic effect if the geometric heuristic and fluence-based local search 
techniques are combined?   
 
This work quantifies the clinical effect of new techniques for optimizing non-coplanar 
VMAT and aims to widen the therapeutic window of radiotherapy for primary brain tumours.  
We demonstrate that a less computationally intense geometric heuristic technique is sufficient 
to produce high quality plans.  Our goal is to facilitate the introduction of non-coplanar 
VMAT into neuro-oncology clinical practice. 
  
Materials and Methods 
Patient selection and treatment planning 
Fifteen patients treated with radiotherapy for primary brain tumours were planned using 
VMAT.  Mean and standard deviation planning target volume (PTV) size was 336.6 ± 214.1 
cc (range 5.5 – 723.6 cc), with a CTV-PTV margin of 3 mm in all cases.  Original PTV 
prescription doses were 60 Gy in 2 Gy fractions, and 54 Gy or 59.4 Gy in 1.8 Gy fractions.  
One patient had palliative treatment (30 Gy in 6 Gy fractions) but was replanned to an 
appropriate radical dose (60 Gy in 2 Gy fractions) for this study.  Further information for 
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each patient case is contained in Supplementary Table A1.  Coplanar and non-coplanar 
radiotherapy plans were produced for a 6 MV Elekta Synergy linear accelerator (Elekta AB, 
Stockholm, Sweden) with Agility multi-leaf collimator [20].  Coplanar VMAT planning used 
our standard clinical technique of a single arc with 180 control points, however to avoid bias 
due to the additional degrees of freedom available to non-coplanar methods, dual arc coplanar 
plans with 360 control points were also produced. 
 
Plans were optimized using an in-house VMAT planning system [21, 22] (AutoBeam v5.5a), 
adapted to import complex couch trajectories [16].  The planning process is summarized here, 
with the detailed workflow included in Supplementary Figure A1.  AutoBeam performed 
fluence optimization at each control point before sequencing the fluence maps into 
deliverable connected VMAT apertures.  As sequencing degraded the dose distribution, direct 
aperture optimization was performed subject to machine limits for VMAT delivery.  Further 
detail on AutoBeam and the optimization techniques used at each stage can be found 
elsewhere [21, 22]. 
 
All cases used the same optimization objectives (Supplementary Table A2) to ensure a fair 
comparison.  AutoBeam plans were reconstructed in Pinnacle3 (Pinnacle3 v9.8, Philips 
Medical, Madison, WI) for final dose calculation in line with clinical practice.  Dose was 
prescribed to the PTV mean value and calculated on a 2.5 x 2.5 x 2.5 mm3 resolution dose 
grid using the Adaptive Convolve algorithm. 
 
Trajectory optimization 
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Three non-coplanar VMAT trajectory optimization techniques were developed in MATLAB 
(R2010b, The MathWorks, Natick, MA): a geometric heuristic technique (GH), a fluence-
based local search technique (FBLS), and the combination of GH and FBLS (FBLS+GH).  
Organs at risk used in trajectory optimization were the brainstem, globes, optic nerves, optic 
chiasm, lenses, hippocampi, temporal lobes, cochleae, and the volume of brain excluding the 
PTV and other OARs.  A patient voxel size of 5 x 5 x 5 mm3 was used during trajectory 
optimization. For ray tracing, a beam aperture was defined as the projection of the PTV onto 
the isocentre plane and rays were cast through the centre of 2.5 x 2.5 mm2 beam elements.  A 
2 mm margin was applied to the optic nerves, lenses, optic chiasm, and cochleae during 
trajectory optimization to prevent small OARs being missed in this step. 
 
Geometric heuristic technique 
The geometric heuristic technique (Figure 1(a)) is an extension of the algorithm described in 
[16]; further detail is provided in Supplementary Figure A1.  Ray tracing was performed 
through the patient to determine a cost based on OAR geometry for all achievable isocentric 
beam orientations (Figure 1(a), step 1).  The trajectory optimization was formulated as a 
graph search problem, with the cost for a given beam orientation being the penalty applied for 
adding that orientation to the VMAT trajectory, and solved using Dijkstra’s least-cost path 
algorithm [23] (Figure 1(a), step 2).  Single arc trajectories were produced through 358° of 
gantry rotation, from 179° to 181°, with control points spaced every 2° of gantry or couch 
rotation.  Sections of trajectory with continuous couch rotation but static gantry rotation were 
allowed, provided the overall trajectory cost was minimised. 
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For this study the technique was extended to incorporate multiple OARs of different relative 
importance and prevent large or less important OARs from dominating the cost for a given 
beam orientation, a limitation of the previous method [16].  The cost, C, for each orientation 
is given by the sum of the relative volumes of each OAR intersected during ray tracing, 
weighted by their relative importance (Equation 1).  
 
  Eq. 1 
where an OAR, v, from all clinically important OARs, V, with relative importance i, has n of 
N voxels intersected by rays cast from a beam orientation with couch angle, c, and gantry 
angle, g.  The importance factors, i, were those used during plan optimization 
(Supplementary Table A2) and chosen based on relative clinical priority. 
 
Fluence-based local search 
One limitation of GH is that individual beam orientation costs, and therefore trajectories, do 
not evaluate the effect of fluence modulation around the arc.  In some cases it may be 
beneficial to deliver dose to the PTV from beam angles which irradiate through an OAR, 
provided modulation is used to reduce the fluence directed at the OAR e.g. through the 
contralateral optics.  GH would overlook these high cost beam orientations even if they might 
be included in a dosimetrically optimal trajectory.  FBLS was developed to investigate the 
effect on plan dosimetry of local modifications, based on fluence modulation, to a supplied 
trajectory. 
 
FBLS was applied to a coplanar VMAT trajectory to determine if it alone could significantly 
improve dosimetry.  FBLS was also applied to a GH trajectory to investigate nearby 
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trajectories that, although not optimal in terms of geometric avoidance over the whole arc, 
might improve overall plan dosimetry.   
 
FBLS algorithm 
The FBLS algorithm (Figure 1(b)) is described below; further detail is provided in 
Supplementary Figure A1.  The initial VMAT trajectory was downsampled to a 15-beam 
IMRT arrangement, approximately equispaced in gantry rotation (Figure 1(b), step 1).  For 
each beam orientation, a simplified primary beam model [24] was used to map the influence 
of each ray, j, on the dose, D, to a patient voxel, i, according to Equation 2. 
 
  Eq. 2 
where SID is the source to isocentre distance, SSD is the source to patient surface distance, d 
is the depth of the calculation point, µ is the attenuation coefficient of water for a nominal 6 
MV therapeutic beam (0.0495 cm-1) and dw is the water equivalent depth of the calculation 
point. 
 
Fluence map optimization (FMO) was performed on the 15-beam IMRT plan to characterise 
the dosimetry of the VMAT trajectory with a similar resolution to Bzdusek et al. [25] for 
coplanar VMAT planning.  FMO proceeded for 30 iterations of iterative least squares [21] 
using the clinical treatment planning objectives (Supplementary Table A2).  The deviation of 
each objective, weighted by its corresponding importance factor, was determined and then 
summed to form a local search objective function.   
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The couch rotation of the first beam orientation was perturbed by a step size of ±10°, with 
new FMO performed, and the change that most improved the objective function was accepted 
(Figure 1(b), step 2).  For each beam in turn, repeated perturbations were performed and 
accepted until there was no absolute improvement in the objective function from adjusting 
the current beam (Figure 1(b), step 3).  The perturbation step size was then reduced 
incrementally from 10° to 2° and the perturbation stage repeated for each beam at its new 
couch angle (Figure 1(b), step 4).  The set of all new beam orientations was then incorporated 
into the original trajectory using MATLAB’s piecewise cubic hermite polynomial 
interpolation [26].  Checks were performed to ensure the interpolated trajectory avoided 
collision regions and did not extend beyond the initial arc start and stop gantry angles.  
Finally, the trajectory was resampled to maintain the same number of control points as the 
input trajectory (Figure 1(b), step 5).  
 
Plan evaluation 
Dose statistics were compared for all plans, with OAR doses judged against relevant 
QUANTEC constraints [1].  Dose-volume statistics linked to cognitive performance, V10Gy 
and V40Gy for the hippocampi, and V40Gy and V60Gy for the temporal lobes [27], were also 
compared.  The probability of radiation induced cognitive impairment, as measured by the 
Wechsler Memory Scale-III Word List Delayed Recall (WMS-III WL-DR) test, was 
calculated from the equivalent dose in 2 Gy fractions to 40% of the bilateral hippocampi 
(EQD2 40%) according to the NTCP model proposed by Gondi et al. [6].  All plans were 
compared against monitor units required, homogeneity index [28] (HI):  
!" = !!%!!!"%!!"% ×100   Eq. 3 
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where D2%, D98% and D50% are the doses to 2 %, 98 % and 50 % of the PTV respectively, 
 
van’t Riet’s conformation number [29] (CN): 
!" = !!,!"%!! × !!,!"%!!"%     Eq. 4 
where VT is the volume of the PTV, V95% is the volume of the 95 % isodose, and VT,95% is the 
volume of the PTV encompassed by the 95 % isodose, 
 
and gradient index (GI):   
!" = !!"%!!"%    Eq. 5 
where V50% and V95% are the volumes of the 50 % and 95 % isodoses respectively. 
 
Statistical analysis was performed using a two-tailed Wilcoxon signed-rank matched-pairs 
test in SPSS (v22, IBM Corporation, Armonk, New York), with comparisons judged 
significant if p < 0.05.  Single and dual arc coplanar VMAT were compared to determine if 
adding additional control points significantly improved the plans produced.  All three non-
coplanar techniques were compared with coplanar VMAT.  The effect of combining the two 
optimization approaches was determined by comparing GH with FBLS+GH.   
 
Results 
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Dual arc coplanar plans were not significantly different from single arc coplanar for most 
metrics studied (Supplementary Table A3).  However, the contralateral optic nerve, 
hippocampus and temporal lobe, and body excluding PTV dose statistics and gradient index 
showed modest improvements.  In all cases where metrics were improved by dual arc 
planning, statistical significance tests against non-coplanar VMAT were unaffected by the 
number of coplanar arcs.  As the number of control points used for single arc coplanar plans 
(180) was similar to non-coplanar plans (median 180, range 180 – 202 for GH and 
FBLS+GH; 180 for FBLS), remaining comparisons are against single arc coplanar VMAT 
only.   
 
Coronal sections through all plans for a representative patient case are presented in Figure 2.  
Note how the orientation of the isodose levels in the non-coplanar plans differs from the 
coplanar case to avoid the OARs, particularly for the 50 % and 20 % isodoses.  Trajectories 
for all plans for one patient case are shown in Figure 3 overlaid on the cost map of the 
geometric heuristic technique.  Regions of the cost map with high cost indicate beam 
orientations where a large proportion of clinically important organs at risk would be 
irradiated by a beam aperture conforming to the projection of the PTV.  Low cost regions 
indicate beam orientations where no OARs, or a small proportion of low importance OARs, 
would be irradiated.  Potential collision regions, estimated with a volunteer lying on the 
treatment couch, are shown in white. 
 
Mean relative dose or volume deviations of clinically relevant OAR statistics from the 
coplanar VMAT plan are presented in Figure 4, with negative values indicating reductions 
and error bars indicating ±1 standard deviation.  Complete results, including absolute dose 
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statistics and statistical comparisons, are presented in Table 1.  All three non-coplanar 
trajectory optimization techniques significantly reduced doses to the contralateral globe, optic 
nerve, hippocampus (mean dose and V40Gy), temporal lobe (mean dose and V40Gy), and 
cochlea.  Additionally GH and FBLS+GH significantly reduced the contralateral lens dose 
and contralateral hippocampus V10Gy; GH also reduced the mean brainstem dose.  FBLS 
significantly increased doses to the ipsilateral globe, optic nerve (mean), and lens.  Compared 
to GH, FBLS+GH significantly increased dose to the brainstem, contralateral optics, 
ipsilateral hippocampus (mean dose and V40Gy), ipsilateral temporal lobe (mean), and body 
excluding PTV.   
 
PTV homogeneity index increased for GH (p = 0.004) and FBLS+GH (p = 0.013) plans 
compared with coplanar VMAT.  However, FBLS+GH improved homogeneity over GH (p = 
0.009).  PTV coverage was less conformal for GH (p = 0.033), FBLS (p = 0.002), and 
FBLS+GH (p = 0.015) compared with coplanar VMAT.  Gradient index was improved by 
FBLS (p = 0.001) and FBLS+GH (p = 0.029) plans compared with coplanar; FBLS+GH 
plans also improved over GH (p = 0.004).  Non-coplanar plans required more monitor units 
than coplanar VMAT (p = 0.001 for all techniques) but there was no difference between GH 
and FBLS+GH. 
 
Predicted clinical effect 
Whole body D1cc to patients with 59.4 Gy and 60 Gy prescriptions exceeded 60 Gy for all 
techniques (maximum 63.5 Gy), suggesting a risk of brain necrosis of 3-5 % [2].  Although 
non-coplanar techniques showed small increases in D1cc, these are unlikely to result in 
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clinically significant differences in symptomatic necrosis risk.  No patient received 59 Gy to 
more than 10 cc of the brainstem, complying with QUANTEC constraints [1].   
 
QUANTEC optic nerve or chiasm constraints (maximum dose < 55 Gy) were exceeded in 
eight patients.  Constraints were exceeded for the ipsilateral optic nerve in four patients, and 
the contralateral optic nerve in one patient, for all coplanar and non-coplanar plans.  For 
patient 2, the ipsilateral optic nerve maximum dose increased to 55.3 Gy for GH from 54.8 
Gy for coplanar VMAT, but reduced to 54.4 Gy with FBLS+GH.  Seven patients exceeded 
the optic chiasm constraint, of which five exceeded the constraint for all coplanar and non-
coplanar plans.  For patient 4, the maximum chiasm dose increased to 56.6 Gy and 55.8 Gy 
for GH and FBLS+GH respectively from the initial coplanar VMAT dose of 54.4 Gy.  For 
patient 6, the maximum chiasm dose was reduced to below the constraint for all non-coplanar 
plans from the initial coplanar VMAT dose of 55.1 Gy.  QUANTEC suggests the threshold 
for optic neuropathy may be 59 Gy for non-pituitary tumours at these fraction sizes [4].  One 
case with a prescription dose of 60 Gy (patient 8) exceeded 59 Gy to the ipsilateral optic 
nerve and chiasm; this was breached for all plans including coplanar VMAT.  None of these 
changes in dose would be expected to significantly affect the likelihood of radiation induced 
optic neuropathy.  
 
There was no difference in the number of patients breaching the QUANTEC cochlear dose 
constraints between techniques at either the standard 45 Gy or conservative 35 Gy levels, 
corresponding to a 30 % chance of hearing loss.  However, the significant reduction in 
contralateral cochlear dose demonstrated by the non-coplanar techniques could reduce the 
likelihood of hearing loss. 
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Dose volume histograms (DVH) of the contralateral hippocampus and temporal lobe for three 
representative patient cases are shown in Figure 5.  Contralateral hippocampus and temporal 
lobe V40Gy were significantly reduced by all non-coplanar techniques, while contralateral 
hippocampus V10Gy was reduced by GH and FBLS+GH.  Median overlap of the bilateral 
hippocampi with the PTV was 29.2 % (range 0 - 59.5 %), with six patients having an overlap 
of more than 40 %.  The probability of cognitive impairment for GH plans (mean ± 1 S.D., 
0.875 ± 0.263) was significantly reduced from coplanar VMAT (0.936 ± 0.183, p = 0.028).  
FBLS+GH significantly increased cognitive impairment probability (0.898 ± 0.229, p = 
0.028) over GH, but remained significantly reduced over coplanar VMAT (p = 0.043).  
 
Discussion 
This work evaluates three non-coplanar VMAT trajectory optimization techniques for a 
cohort of primary brain tumour patients.  Having performed a systematic comparison of these 
techniques, alone and in combination, we can draw some specific conclusions regarding their 
relative merits.  FBLS achieved additional contralateral OAR sparing over coplanar VMAT 
plan, while maintaining PTV homogeneity, but increased dose to ipsilateral OARs.  
FBLS+GH maintained much of the OAR sparing of GH while recovering some lost PTV 
dose homogeneity.  The trade-off between PTV dose homogeneity and OAR sparing depends 
on the planning objectives used, while the extent to which individual OARs are spared 
depends on their relative importance for the specific clinical case.  For this cohort, it is 
important to maximize OAR sparing and therefore the geometric heuristic technique is 
recommended for primary brain tumours. 
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Recent work has proposed different heuristic or fluence-based methods of trajectory 
optimization [10, 16-19].  Fluence-based techniques solved non-coplanar IMRT beam 
orientation problems for up to 20 beams but did not evaluate the dosimetry of the connecting 
paths [18, 19]; therefore the final VMAT trajectories may not be globally optimal.  FBLS 
accepted only local changes that decreased the local search objective function and therefore 
did not guarantee the altered VMAT trajectory was optimal.  However, it did allow the 
dosimetry of alternate trajectories to be investigated while maintaining the quality of the rest 
of the connected trajectory.  The complexity of FBLS was limited by using a simplified beam 
model; further work to incorporate a clinical dose model and determine its effect on trajectory 
optimization is planned.  
 
More general issues regarding the potential clinical implementation of dynamic couch non-
coplanar VMAT have yet to be fully addressed.  While modern linear accelerators can deliver 
non-coplanar VMAT [10, 17], there has been no systematic investigation of its delivery 
accuracy or efficiency.  Although statistically significant, coplanar and non-coplanar monitor 
units were sufficiently similar that we expect delivery efficiency to depend on couch rotation 
speed.  Potential differences in delivery efficiency between non-coplanar trajectories will 
depend on gantry rotation, couch rotation, and dose rate limits for the specific machine.  
Dynamic couch rotation requires extra quality assurance testing [30] and advanced collision 
prediction and detection methods [31].  Patient rotation during treatment could introduce 
intra-fractional motion, with the effect dependent on treatment site and couch trajectory.  
Although additional immobilization is unlikely to be necessary for intracranial treatments, 
this may be a significant issue for other body sites and requires investigation.  An alternative 
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linac configuration capable of rotation around the vertical axis allows non-coplanar treatment 
without patient movement and would address some of these problems [32, 33].  However, the 
reduced range of rotation achievable [32] may limit the utility of this approach for 
intracranial sites.  The trajectory optimization techniques described in this work are 
applicable to all delivery platforms, within machine limitations. 
 
Non-coplanar VMAT demonstrated improved sparing of functionally important OARs, 
notably significantly decreasing dose to the contralateral temporal lobe and hippocampus 
(Figure 5).  Neurocognitive decline has been linked to higher doses to the hippocampi [6, 27, 
34, 35] and temporal lobes [27, 34, 36].  Redmond et al. found reductions in children’s motor 
speed and dexterity were correlated with increased dose to the hippocampi and temporal 
lobes, while visual perception decreased with increasing dose to the left temporal lobe [34].  
Jalili et al. found children and young adults receiving greater than 43.2 Gy to 13 % of the left 
temporal lobe were significantly more likely to demonstrate a reduction in intelligence 
quotient (IQ) of 10 % or more [36].  The effect of hippocampal sparing in whole brain 
radiotherapy is currently under active investigation in several clinical trials worldwide, and 
has shown promising results in the RTOG 0933 phase 2 trial [35].  Gondi et al. modelled the 
probability of impaired learned-word recall with increasing dose to the hippocampi for a 
cohort of adult patients [6].  Gondi et al.’s NTCP model of cognitive injury due to 
hippocampal dose results in a rather stringent hippocampal dose sparing requirement (D40% to 
the bilateral hippocampi leading to a 50% probability of WMS-III WL-DR impairment 
(EQD502) was estimated to be 14.88 Gy [95% CI, 12.86-17.06 Gy]) that may be difficult to 
achieve in practice for patients treated for primary brain tumours where intra-cranial tumour 
control is the priority.  While the modelled hippocampal NTCP reductions achieved by non-
coplanar VMAT were modest, the absolute dose reductions achieved for the contralateral 
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temporal lobe and hippocampus (Figure 5) are likely to be clinically significant [27].  These 
studies suggest that non-coplanar VMAT using dynamic couch rotation should reduce the 
incidence and severity of neurocognitive side effects by limiting dose to the contralateral 
temporal lobe and hippocampus.  The potential benefit of non-coplanar VMAT for a 
homogeneous cohort of primary brain tumour patients should now be evaluated within a 
clinical trial. 
 
Conclusions 
Non-coplanar VMAT trajectories using GH significantly spared contralateral OARs over 
coplanar VMAT for primary brain tumours.  Both fluence-based trajectories emphasized PTV 
homogeneity over OAR sparing, although FBLS+GH maintained most of the OAR sparing 
achieved by GH.  However, for primary brain tumour patients, organ at risk sparing is 
clinically more important than the relatively small differences in PTV homogeneity.  
Therefore, non-coplanar VMAT using the geometric heuristic technique is recommended to 
reduce normal tissue complication probability for primary brain tumour patients. 
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Table 1.  Mean and standard deviations of dose statistics for coplanar and geometric heuristic 
technique (GH), fluence-based local search (FBLS), and combined GH and FBLS 
(FBLS+GH) non-coplanar VMAT trajectories.  Significant statistical comparisons (p < 0.05) 
are indicated as follows: (a) coplanar vs GH, (b) coplanar vs FBLS, (c) coplanar vs 
FBLS+GH, (d) GH vs FBLS+GH, (e) GH vs FBLS, (f) FBLS vs FBLS+GH.  Ipsi and contra 
= ipsilateral and contralateral.  Dx = dose to volume x.  VxGy = relative volume receiving x 
Gy. 
 
Figure 1. Non-coplanar trajectory optimization methods for (a) the geometric heuristic 
technique (GH), and (b) the fluence-based local search (FBLS) algorithm.  Followed left to 
right, (b) shows how the FBLS algorithm updates at each numbered step.  As the example 
shown uses GH as its initial trajectory, (b) would produce a FBLS+GH trajectory.  All 
trajectories are overlaid on the normalised GH cost map.  White regions indicate excluded 
potential collision regions; high cost regions indicate orientations where a beam aperture 
conforming to the PTV would irradiate multiple or high importance organs at risk.  In (b), 
black and grey circles indicate current and previously considered beam orientations 
respectively; the dashed line indicates the new trajectory.     
 
Figure 2. Coronal sections for Case 4, showing plans for (a) coplanar VMAT, (b) the 
geometric heuristic technique (GH), (c) the fluence-based local search (FBLS), and (d) the 
combination of GH and FBLS (FBLS+GH).  PTV (pink colorwash), hippocampus (orange), 
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temporal lobe (yellow), brainstem (red), and cochlea (purple) are shown.  Isodose lines are 
95% (green), 80% (blue), 50% (lilac), and 20% (brown) of prescription dose.  
 
Figure 3. VMAT trajectories for (a) the geometric heuristic technique (GH), (b) fluence-
based local search (FBLS), and (c) and the combination of GH and FBLS (FBLS+GH).  All 
trajectories are overlaid on the normalised cost map for the geometric heuristic technique.  
White regions indicate excluded potential collision regions; high cost regions indicate 
orientations where a beam aperture conforming to the PTV would irradiate multiple or high 
importance organs at risk.  
 
Figure 4.  Mean relative deviations from single arc VMAT of clinically relevant organ at risk 
(a) maximum dose, (b) mean dose, and (c) dose volume statistics for the geometric heuristic 
technique (GH), fluence-based local search (FBLS), and combined GH and FBLS 
(FBLS+GH).  Error bars show ± 1 standard deviation.  Vx = relative volume receiving x Gy; 
I. = ipsilateral; C. = contralateral; temp. = temporal lobe; hippo. = hippocampus. 
 
Figure 5.  PTV and contralateral hippocampus (a, c, e) and contralateral temporal lobe (b, d, 
f) dose volume histograms for the geometric heuristic technique (GH), fluence-based local 
search (FBLS), and combined GH and FBLS (FBLS+GH), for representative patient cases 
with small (top; Case 1), medium (middle; Case 9), and large (bottom; Case 15) PTV 
volumes.    
	
Gantry angle (°)
Co
uc
h 
an
gle
 (°
)
−80
−60
−40
−20
0
20
40
60
80
−150 −100 −50 0 50 100 150
0.0
0.2
0.4
0.6
0.8
1.0
1. Calculate single-beam cost map 2. Determine least-cost trajectory
    through the cost map
(a)
Gantry angle (°)
Co
uc
h 
an
gle
 (°
)
−80
−60
−40
−20
0
20
40
60
80
−150 −100 −50 0 50 100 150
0.0
0.2
0.4
0.6
0.8
1.0
1. Convert initial trajectory
    into 15 fixed beams
2. Accept changes to
    each beam in turn
4. Refine search
    on each pass
3. Repeat for all beams
5. Interpolate
    new trajectory
(b)

(a)
Gantry angle (°)
Co
uc
h 
an
gle
 (°
)
−80
−60
−40
−20
0
20
40
60
80
−150 −100 −50 0 50 100 150
0.0
0.2
0.4
0.6
0.8
1.0
(b)
Gantry angle (°)
Co
uc
h 
an
gle
 (°
)
−80
−60
−40
−20
0
20
40
60
80
−150 −100 −50 0 50 100 150
0.0
0.2
0.4
0.6
0.8
1.0
(c)
Gantry angle (°)
Co
uc
h 
an
gle
 (°
)
−80
−60
−40
−20
0
20
40
60
80
−150 −100 −50 0 50 100 150
0.0
0.2
0.4
0.6
0.8
1.0
Br
ain
ste
m
 m
ax
I. 
glo
be
 m
ax
C.
 g
lob
e 
m
ax
I. 
op
tic
 n
er
ve
 m
ax
C.
 o
pt
ic 
ne
rv
e 
m
ax
Ch
ias
m
 m
ax
I. 
len
s m
ax
C.
 le
ns
 m
ax
Re
lat
ive
 d
os
e 
de
via
tio
n 
(%
)
−30
−20
−10
0
10
20
FBLS+GH
FBLS
GH
(a)
I. 
hip
po
. m
ea
n
C.
 h
ipp
o. 
m
ea
n
I. 
te
m
p. 
lob
e 
m
ea
n
C.
 te
m
p. 
lob
e 
m
ea
n
I. 
co
ch
lea
 m
ea
n
C.
 co
ch
lea
 m
ea
n
Re
lat
ive
 d
os
e 
de
via
tio
n 
(%
)
−50
−40
−30
−20
−10
0
10
20(b)
I. 
hip
po
. V
10
Gy
I. 
hip
po
. V
40
Gy
C.
 h
ipp
o. 
V1
0G
y
C.
 h
ipp
o. 
V4
0G
y
I. 
te
m
p. 
lob
e 
V4
0G
y
I. 
te
m
p. 
lob
e 
V6
0G
y
C.
 te
m
p. 
lob
e 
V4
0G
y
C.
 te
m
p. 
lob
e 
V6
0G
y
Re
lat
ive
 vo
lum
e 
de
via
tio
n 
(%
)
−80
−60
−40
−20
0
20
(c)
0 10 20 30 40 50 60
0
20
40
60
80
100
Dose (Gy)
Vo
lum
e 
(%
)
PTV
Hippocampus
(a)
0 10 20 30 40 50 60
0
20
40
60
80
100
Dose (Gy)
Vo
lum
e 
(%
)
Coplanar
GH
FBLS
FBLS+GH
(b)
0 10 20 30 40 50 60
0
20
40
60
80
100
Dose (Gy)
Vo
lum
e 
(%
)
PTV
Hippocampus
(c)
0 10 20 30 40 50 60
0
20
40
60
80
100
Dose (Gy)
Vo
lum
e 
(%
)
(d)
0 10 20 30 40 50 60
0
20
40
60
80
100
Dose (Gy)
Vo
lum
e 
(%
)
PTV
Hippocampus
(e)
0 10 20 30 40 50 60
0
20
40
60
80
100
Dose (Gy)
Vo
lum
e 
(%
)
(f)
Pinnacle3 calculation
Trajectory 
optimization
Patient 
data
VMAT 
trajectory
VMAT 
apertures
AutoBeam planning
Stop 
angle 
reached?
Perform ray tracing for current orientation
Output trajectory
Determine beam cost and add to cost map
All couch 
rotations 
visited?
NO
NO
YES
YES
(a)
(b)
Final 
beam?
Input trajectory
Convert to IMRT problem & optimize fluence
Perturb couch rotation of current beam
Minimum 
step 
size?
Interpolate new trajectory
Move to next beam
Optimize fluence and evaluate cost function
Cost 
function 
reduced?
NO
NO
NO
YES
YES
YES
(c)
Start 
angle for 
gantry 
arc
Stop 
angle for 
gantry 
arc
Convert cost map into graph problem 
Run Dijkstra’s algorithm on graph problem
Increment 
gantry angle
Increment 
couch angle 
Initial 
couch 
angle
Reduce step size and 
return to first beam
Fluence 
optimization
Arc sequencing
Aperture 
optimization
VMAT arc 
construction
Dose calculation
Accept 
perturbation
Figure A1. Flowchart showing (a) the non-coplanar trajectory planning workflow, (b) the geometric heuristic technique, and (c) 
the fluence-based local search algorithm.
Case  Diagnosis Age at diagnosis (yrs) PTV volume (cc)  Mean PTV dose (Gy) 
1  Craniopharyngioma   21   5.5   54 
2  Craniopharyngioma   16   31.7  54 
3  Oligoastrocytoma   48   554.2   54 
4  Astrocytoma    46   505.6   54 
5  Astrocytoma   9    151.2   54 
6 Glioblastoma   34   309.2  60 
7 Glioblastoma   69   502.3  60 
8 Glioblastoma   41   279.7  60 
9 Glioma   79   271.0  60* 
10 Astrocytoma   62   572.6  59.4 
11 Glioneural tumour  18   84.2  54 
12 Desmoplastic ganglioglioma 4   237.7  54 
13 Glioblastoma   63   368.7  60 
14 Glioma   42   451.8  60 
15 Glioma   37   723.6  54  
 
Table A1.  Summary of patient diagnoses and prescriptions.* = original prescription 
30 Gy in 6 fractions. 
Region of interest Objective Relative importance 
PTV Minimize RMS around prescription dose 100 
Brainstem Minimize maximum dose 10 
Globes Minimize maximum dose 5 
Optic nerves Minimize maximum dose 5 
Optic chiasm Minimize maximum dose 5 
Lenses Minimize mean dose 5 
Hippocampi Minimize mean dose 3 
Temporal lobes Minimize mean dose 2 
Cochleae Minimize mean dose 1 
Brain excluding other ROIs Minimize mean dose 1 
Table A2.  AutoBeam optimization parameters.  RMS = root mean square deviation.  ROI = 
region of interest.  Lens mean dose, not maximum dose, is used during optimization in 
routine clinical VMAT planning at our centre. 
 
Region of interest / metric Statistic Mean ± 1 S.D. 
  Single arc Dual arc 
 D98%  (Gy) 54.6 ± 3.0 54.6 ± 3.0 
PTV D50% (Gy) 56.8 ± 3.1 56.9 ± 3.1 
 D2% (Gy) 58.2 ± 3.2 58.2 ± 3.2 
Brainstem DMax (Gy)  54.7 ± 4.6 54.7 ± 4.7 
  DMean (Gy) 29.3 ± 12.5 29.2 ± 12.5 
Ipsi. Globe DMax (Gy) 25.0 ± 12.1 25.3 ± 12.2 
 DMean (Gy) 16.2 ± 7.7 16.5 ± 7.9 
Contra. Globe DMax (Gy) 19.3 ± 6.6 19.2 ± 6.7 
 DMean (Gy) 13.3 ± 5.0 13.2 ± 5.0 
Ipsi. Optic Nerve DMax (Gy) 41.9 ± 15.5 41.9 ± 15.5 
 DMean (Gy) 29.9 ± 12.3 30.1 ± 12.4 
Contra. Optic Nerve DMax (Gy) 34.6 ± 13.6 34.2 ± 13.7 
 DMean (Gy) 22.3 ± 7.8 22.1 ± 7.9 
Chiasm DMax (Gy) 51.2 ± 9.3 51.2 ± 9.3 
Ipsi. Lens DMax (Gy) 15.2 ± 7.3 15.5 ± 7.5 
 DMean (Gy) 12.8 ± 6.5 13.1 ± 6.8 
Contra. Lens DMax (Gy) 13.2 ± 5.1 13.1 ± 5.2 
 DMean (Gy) 11.1 ± 4.7 11.0 ± 4.8 
Ipsi. Hippocampus DMean (Gy) 46.7 ± 14.8 46.7 ± 14.7 
 V10Gy (%) 97.3 ± 9.4 97.5 ± 8.6 
 V40Gy (%) 74.0 ± 41.9 74.1 ± 41.9 
Contra. Hippocampus DMean  (Gy) 30.4 ± 9.5 29.9 ± 9.3 
 V10Gy (%) 97.0 ± 11.5 97.1 ± 11.4 
 V40Gy (%) 16.3 ± 22.2 14.7 ± 21.4 
Ipsi. Temporal Lobe DMean (Gy) 41.5 ± 15.9 41.6 ± 15.9 
 V40Gy (%) 59.7 ± 38.2 59.8 ± 38.2 
 V60Gy (%) 12.0 ± 21.8 12.0 ± 21.6 
Contra. Temporal Lobe DMean (Gy) 23.6 ± 7.2 23.0 ± 6.9 
 V40Gy (%) 5.0 ± 6.0 4.3 ± 5.7 
 V60Gy (%) 0.0 ± 0.0 0.0 ± 0.0 
Ipsi. Cochlea DMean (Gy) 27.8 ± 22.5 27.9 ± 22.5 
Contra. Cochlea DMean (Gy) 12.9 ± 8.4 12.7 ± 8.2 
Body excluding PTV DMean (Gy) 11.6 ± 4.2 11.5 ± 4.2 
Body D1cc (Gy) 58.4 ± 3.4 58.4 ± 3.4 
Monitor units  238.7 ± 15.7 238.9 ± 15.9 
Homogeneity index (%) 6.308 ± 0.846 6.353 ± 0.790 
Gradient index  2.708 ± 0.700 2.692 ± 0.705 
Conformation number  0.791 ± 0.064 0.791 ± 0.065 
 
Table A3.  Mean and standard deviations of dose statistics for single and dual arc 
coplanar VMAT.  Significant statistical comparisons (p < 0.05) are indicated in bold.  
Ipsi and contra = ipsilateral and contralateral.  Dx = dose to volume x.  VxGy = 
relative volume receiving x Gy.  
